title: H2-receptor antagonists an Helicobacter pylori eradication.
abstract: BACKGROUND
  To discuss the place of histamine H2-receptor antagonists in eradication therapy of Helicobacter pylori.
  
  
  METHODS
  Analysis of two papers in this supplement and the relevant literature.
  
  
  RESULTS
  Triple therapy comprising ranitidine and two antibiotics is effective in speeding up healing of duodenal ulcer and eradicating H. pylori from the stomach.
  
  
  CONCLUSIONS
  Ranitidine is to be considered as a valuable and safe component of triple therapy against H. pylori in duodenal ulcer patients.
authors.affiliation: Dept. of Gastroenterology-Hepatology, University Hospital, Leiden, The Netherlands.
authors.forename: C B
authors.initials: CB
authors.lastname: Lamers
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000382:microbiology; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D011899:Ranitidine / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D011899:Ranitidine